Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Amifampridine (3,4-diaminopyridine) | 54-96-6 | 99.99% | 109.13 | 50 G
SDP

Catalog No. 5000360256
Encompass_Preferred

Amifampridine (3,4-diaminopyridine) is an orally active, potent, and cell permeable voltage-gated potassium (Kv) channel blocker. It demonstrates efficacy in reversing BoNT/A intoxication and enhances transmitter release from neuromuscular junctions. This product is suitable for research related to Lambert-Eaton myasthenic syndrome (LEMS).

  • Orally active, potent, and cell permeable voltage-gated potassium channel blocker.
  • Demonstrates efficacy in the reversal of BoNT/A intoxication.
  • Increases transmitter release from neuromuscular junctions.
  • Can be used for lambert-eaton myasthenic syndrome research.

Catalog No. 50-003-60256 Supplier Medchemexpress LLC Supplier No. HY1494650G
May include imposed supplier surcharges.
Add to Cart
Add to Cart

Amifampridine (3,4-diaminopyridine) is an orally active, potent, and cell permeable voltage-gated potassium (Kv) channel blocker. It demonstrates efficacy in reversing BoNT/A intoxication and enhances transmitter release from neuromuscular junctions. This product is suitable for research related to Lambert-Eaton myasthenic syndrome (LEMS).

  • Orally active, potent, and cell permeable voltage-gated potassium channel blocker.
  • Demonstrates efficacy in the reversal of BoNT/A intoxication.
  • Increases transmitter release from neuromuscular junctions.
  • Can be used for lambert-eaton myasthenic syndrome research.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.